Importer’s and Wholesaler’s Licences: Why Import Plus Wholesale Needs Two

1. Key takeaways

Yes. A Singapore importer’s licence authorises only the bringing of a medical device into Singapore; it does not authorise wholesale supply. If the licence holder also wants to wholesale, it must obtain a separate Wholesaler’s Licence. HSA states the position directly: licensed importers require a wholesaler’s licence for wholesale supply. Two statutory exceptions apply. A manufacturer supplying devices that it manufactured itself under its Manufacturer’s Licence does not need a wholesaler’s licence, and a wholesaler’s licence is not required for supply to end users, such as in a retail store. Wholesale supply without the correct licence is a criminal offence under section 14 of the Health Products Act 2007: a fine of up to SGD 50,000, up to 2 years’ imprisonment, or both.

• Import is not wholesale. The importer’s licence covers bringing the device into Singapore and nothing beyond that.
• Two licences are normal. Import plus wholesale supply is the most common combination for a Singapore entity and requires both certificates.
• Export sits inside wholesale. The wholesaler’s licence covers supply by wholesale including export.
• Two exceptions are narrow. Manufacturer self-supply and supply to end users are the only carve-outs described by HSA, and neither extends to onward distribution.
• Premises are part of the licence. Storage of health products pending distribution must take place at premises covered by the licence.
• The penalty is criminal. Unlicensed wholesale supply attracts a fine of up to SGD 50,000, up to 2 years’ imprisonment, or both.

2. Legal basis

The requirement sits in Part VI of the Health Products Act 2007 and is amplified by GN-02 R8, the Guidance on Licensing of Manufacturers, Importers and Wholesalers of MD, effective 1 April 2026. HSA’s guidance describes the importer’s licence as permission to bring a medical device into Singapore, then states expressly that licensed importers require a wholesaler’s licence for wholesale supply. The same guidance records the two exceptions: licensed manufacturers do not require a wholesaler’s licence to supply medical devices manufactured under their Manufacturer’s Licence, and a wholesaler’s licence is not required for supply to end-users, such as in a retail store. Section 14 of the Act supplies the prohibition and the sanction, and section 14(2) adds a separate obligation concerning the premises used for storage.

Section 14(1) provides that, unless otherwise provided, no person shall supply a health product by wholesale unless the person holds a valid wholesaler’s licence and supplies in accordance with the licence conditions. Section 14(4) sets the sanction quoted above. Section 14(2) deals with a different risk: a wholesaler must not use any premises or facility to store health products pending distribution unless that premises or facility is authorised under its wholesaler’s licence, or under the Act or by HSA. The licensing question covers not only what the company does but also where the goods sit while it is doing it.

3. Expert insights

Section 14 makes unlicensed wholesale a criminal offence, not a paperwork gap. Commercial teams often treat licensing as administrative; section 14 makes it criminal. Section 14(1) prohibits wholesale supply of a health product without a valid wholesaler’s licence and compliance with its conditions, and section 14(4) attaches a fine of up to SGD 50,000, imprisonment of up to 2 years, or both. Once the sanction is stated in those terms, the conversation about whether a second licence is really necessary usually ends.

Section 14(2) contains a warehouse trap. The provision forbids a wholesaler from using premises or facilities to store health products pending distribution unless authorised under its wholesaler’s licence, or under the Act or by HSA. The storage address therefore forms part of the licensed scope. A company that moves warehouse, adds a cold room or outsources storage without updating the licence is in breach even though the licence remains valid. Warehouse changes are driven by operations, so the facilities process needs a regulatory notification trigger.

The definition of end user decides whether a second licence is needed. Supply to the final user in a hospital, clinic or retail store does not require a wholesaler’s licence. Supply to a downstream dealer for re-supply does. The test is whether the counterparty will resell the device. The test becomes harder with a mixed customer base: a hospital group that distributes to affiliated clinics, or a retail chain that resells to independent pharmacies. We list counterparties by category and test each against the re-supply question rather than treating the customer base as one block.

Export activity brings many companies into the wholesaler’s licence unexpectedly. HSA states that the wholesaler’s licence covers supply by wholesale including export. A model that uses Singapore as a regional transit warehouse and re-exports goods to neighbouring countries therefore requires a wholesaler’s licence. This is the most commonly missed certificate in regional headquarters planning, because the goods never enter the local clinical supply chain and the transaction looks like freight forwarding commercially. It is still a regulated supply, and the licence must be in place before the first re-export shipment.

The manufacturer exemption covers only self-manufactured devices. A manufacturer supplying devices it manufactured itself does not need a wholesaler’s licence. Once the same entity imports or supplies devices manufactured by someone else, the exemption does not apply, and the ordinary wholesale licensing rule resumes. Companies that manufacture locally and also import a complementary range sit in a mixed position: one licence covers part of the portfolio, and a second is needed for the rest.

4. Practical recommendations

• Test each counterparty against re-supply. Ask whether the customer will resell; if yes, a wholesaler’s licence is required for that flow.
• Draw the full goods flow. Map import, storage, sale and export, and check the licence position at every step rather than only at the border.
• Bring storage addresses into the licensed scope. A warehouse change, an extra storage room or an outsourced facility should trigger a variation.
• Treat regional transit as wholesale. Re-export models need the wholesaler’s licence before shipment, not after the first customs query.
• File variations promptly. Changes to risk classification, QMS certification and premises information must be notified to HSA and handled as a variation costing SGD 168.
• Keep the manufacturer exemption under review. If the imported range grows, re-test whether the exemption still covers the whole portfolio.

5. Verification checklist

• □ The complete goods flow has been mapped from import through storage, sale and export
• □ Each counterparty category tested against re-supply
• □ Export activity has been included in the wholesaling assessment
• □ All storage addresses fall within the licensed scope
• □ The boundary of the manufacturer exemption has been confirmed for each product
• □ Premises, classification and QMS changes have been planned as variations at SGD 168
• □ The penalty exposure under section 14(4) has been explained to responsible officers

Regulatory information verified as of 26 October 2026. Source tiers: primary (Health Products Act 2007, section 14); secondary (GN-02 R8, HSA dealer licensing page).

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Singapore. Our team prepares dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with HSA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com